In 2023, DPF organised a series of expert interviews and workshops with the aim to explore the
feasibility of a cost-benefit analysis in the environmental risk assessment of
genetically modified organisms used in gene therapy clinical trials. The
research was commissioned by the Dutch Ministry of Infrastructure and Water
Management. The report was submitted to the Dutch Parliament on 14 March 2024:
Rapport Verkenning aanvaardbaar risico gentherapieonderzoek (in Dutch).
in Projects
Daan Schuurbiers
10 juni 2024